儿童肝炎相关再生障碍性贫血的临床特征

段彦龙; 吴润晖; 杨双; 张蕊; 张莉; 周翾; 姜锦; 金眉

PDF(972 KB)

中国当代儿科杂志 ›› 2010, Vol. 12 ›› Issue (08) : 609-612.

论著·临床研究

儿童肝炎相关再生障碍性贫血的临床特征

段彦龙，吴润晖，杨双，张蕊，张莉，周翾，姜锦，金眉

作者信息 +

Clinical features of hepatitis-associated aplastic anemia in children

DUAN Yan-Long, WU Run-Hui, YANG Shuang, ZHANG Rui, ZHANG Li, ZHOU Xuan, JIANG Jin, JIN Mei

Author information +

文章历史 +

摘要

目的：探讨儿童肝炎相关再生障碍性贫血(HAAA)临床特征。方法：回顾性地研究2007年1月至2008年12月该院诊治的HAAA患儿的临床资料，包括临床表现、血常规、骨髓象、病毒血清学、免疫功能指标及治疗和预后。结果：共收治HAAA患儿8例，占同期获得性再生障碍性贫血（再障）的4.9%；男7例、女1例；平均7.5岁（4.4～10.3岁）。肝炎病因不明。患肝炎后至血细胞减少的间隔时间中位数为6周。3例为重症再障（SAA），5例极重型再障（VSAA）。全部病例均有严重T细胞免疫紊乱，Ts细胞明显升高、Th细胞明显下降。4例免疫治疗有效，3例起病1个月内死亡, 1例放弃治疗。结论：儿童HAAA发病率男性高于女性，学龄期多见。HAAA儿童存在严重T细胞免疫紊乱，早期死亡率高，免疫抑制治疗有效。［中国当代儿科杂志，2010，12（8）：609-612］

Abstract

OBJECTIVE: To study the clinical features of hepatitis-associated aplastic anemia (HAAA) in children. METHODS: The clinical data of the children with newly diagnosed HAAA from January 2007 to December 2008 were respectively studied, including clinical manifestations, and blood routine, bone marrow examination, viral serology and immune function results as well as treatment and prognosis. RESULTS: A total of 8 children were confirmed as HAAA, accounting for 4.9% in children with aplastic anemia. There were 7 males and 1 female. The median age was 7.5 years (range 4.4 to 10.3 years) at diagnosis. They had negative serologic results and the causes of hepatitis could not be identified. The median interval from hepatitis occurrence to blood cell reduction was 6 weeks. Three cases were diagnosed as severe aplastic anemia and 5 cases as very severe aplastic anemia. Severe T cell immune disorders were found in all 8 cases. The percentage of Ts cells increased and the percentage of Th cells decreased significantly in the 8 children with HAAA. Four children survived after immune suppress treatment, three children died within one month after diagnosis and one child required own discharge without treatment. CONCLUSIONS: HAAA is more frequent in male school children. The children with HAAA have severe T cell immune disorders, with a higher early death rate. Immune suppress treatment is effective.［Chin J Contemp Pediatr, 2010, 12 (8):609-612］

导出引用

段彦龙, 吴润晖, 杨双, 张蕊, 张莉, 周翾, 姜锦, 金眉. 儿童肝炎相关再生障碍性贫血的临床特征[J]. 中国当代儿科杂志. 2010, 12(08): 609-612

DUAN Yan-Long, WU Run-Hui, YANG Shuang, ZHANG Rui, ZHANG Li, ZHOU Xuan, JIANG Jin, JIN Mei. Clinical features of hepatitis-associated aplastic anemia in children[J]. Chinese Journal of Contemporary Pediatrics. 2010, 12(08): 609-612

中图分类号： R556.5

参考文献

［1］Baumelou E, Guiguet M, Mary JY. Epidemiology of aplastic anemia in France: a case-control study. I. Medical history and medication use. The French Cooperative Group for Epidemiological Study of Aplastic Anemia ［J］. Blood, 1993, 81(6):1471-1478.
［2］张之南,沈悌. 血液病诊断及疗效标准［M］. 第3版. 北京:科学出版社, 2007: 19-23.
［3］中华医学会传染病与寄生虫病分会.病毒性肝炎防治方案［J］. 中华内科杂志, 2001, 40(1): 62-68.
［4］Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS.Hepatitis-associated aplastic anemia ［J］. N Engl J Med, 1997, 336(15): 1059-1064.
［5］Young NS, Issaragrisil S, Chieh CW, Takaku F. Aplastic anaemia in the Orient ［J］. Br J Haematol, 1986, 62(1):1-6.
［6］Kirsch R, Yap J, Roberts EA, Cutz E.Clinicopathologic spectrum of massive and submassive hepatic necrosis in infants and children ［J］. Human Pathol, 2009, 40(4): 516-526.
［7］Pongtanakul B, Das PK, Charpentier K, Dror Y. Outcome of children with aplastic anemia treated with immunosuppressive therapy ［J］. Pediatr Blood Cancer, 2008, 50(1): 52-57.
［8］Savage WJ, DeRusso PA, Resar LM, Chen AR, Higman MA, Loeb DM, et al. Treatment of hepatitis-associated aplastic anemia with high-dose cyclophosphamide ［J］. Pediatr Blood Cancer, 2007, 49(7): 947-951.
［9］Osugi Y, Yagasaki H, Sako M, Kosaka Y, Taga T, Ito T, et al.Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia ［J］. Haematologica, 2007, 92(12): 1687-1690.
［10］Lu J, Basu A, Melenhorst JJ, Young NS, Brown KE. Analysis of T-cell repertoire in hepatitis-associated aplastic anemia ［J］. Blood, 2004, 103(12): 4588-4593.